Kathrin Meyer

Nationwide Children's Hospital — United States

Medicine · Health Sciences

31h-index7.1kcitations141works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurogenetic and Muscular Disorders Research(55), RNA modifications and cancer(26), CRISPR and Genetic Engineering(22), Amyotrophic Lateral Sclerosis Research(18), RNA Research and Splicing(14)

Publications141 total

AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model
Journal of Biomedical Science·2026Open Access
Additional file 1 of AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model
Figshare·2026Open Access
Additional file 1 of AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model
Figshare·2026Open Access
AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model
Figshare·2026Open Access
AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model
Figshare·2026Open Access
Gene replacement therapy for Piga GPI-anchor deficiency in the developing nervous system
2025Open Access
A 3D Non-human Primate Digital Model for Pharmacokinetic Prediction of Intra-Cerebrospinal Fluid Drug Neuraxial Dispersion
2025Open Access
A 3D non-human primate digital model for pharmacokinetic prediction of intra-cerebrospinal fluid drug neuraxial dispersion
Fluids and Barriers of the CNS·2025Open Access
Targeting microRNA-dependent control of X chromosome inactivation improves the Rett Syndrome phenotype
Nature Communications·2025· 7 citedOpen Access
Application of a single series of Mulligan mobilization in a patient with hip joint degeneration – a case study
Acta Elbingensia·2024Open Access
Gene therapy: State of the art precision medicine
Elsevier eBooks·2024
Contributors
Elsevier eBooks·2024Open Access
Combination AAV therapy with galectin-1 and SOD1 downregulation demonstrates superior therapeutic effect in a severe ALS mouse model
Molecular Therapy — Methods & Clinical Development·2024· 10 citedOpen Access
MeCP2 gene therapy ameliorates disease phenotype in mouse model for Pitt Hopkins syndrome
Neurotherapeutics·2024· 6 citedOpen Access
The postnatal injection of AAV9-FOXG1 rescues corpus callosum agenesis and other brain deficits in the mouse model of FOXG1 syndrome
Molecular Therapy — Methods & Clinical Development·2024· 9 citedOpen Access
C9ORF72 patient-derived endothelial cells drive blood-brain barrier disruption and contribute to neurotoxicity
Fluids and Barriers of the CNS·2024· 8 citedOpen Access
RNA helicase IGHMBP2 regulates THO complex to ensure cellular mRNA homeostasis
Cell Reports·2024· 8 citedOpen Access
Editorial: The role of glial cells in neurodegeneration
Frontiers in Molecular Medicine·2024Open Access
AAV-based gene therapy ameliorated CNS-specific GPI defect in mouse models
Molecular Therapy — Methods & Clinical Development·2023· 7 citedOpen Access
Editorial: Personalized medicine for neuromuscular disorders
Frontiers in Cell and Developmental Biology·2023· 3 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Brian K. Kaspar(25), Shibi Likhite(18), Carlos J. Miranda(9), Arthur H.M. Burghes(9), Laura Ferraiuolo(9), Pamela J. Shaw(8), Stephen J. Kolb(8), Lyndsey Braun(7), Kevin D. Foust(7), W. David Arnold(6), Daniel Schümperli(6), Jerry R. Mendell(4), SungWon Song(4), Guillaume M. Hautbergue(4), Monika A. Myszczynska(4), Leah Schmelzer(4), Katherine A. White(4), Samantha S. Davis(4), Tyler B. Johnson(4), Jill M. Weimer(4)